Chen, D., Baer, M., Niyongere, S., Emadi, A., Shastri, V., Lamba, J., Loken, M., Sanglard, L., Lapidus, R., Bentzen, S., Duong, V. (2025). Initial results from a phase 2 study of cladribine, cytarabine, and granulocyte-colony stimulating factor with gemtuzumab ozogamicin (CLAG-GO) for the treatment of patients with relapsed/refractory acute myeloid leukemia. Blood. https://doi.org/10.1182/blood-2025-999